Overview Safety Study of HPP593 in Subjects During and After Limb Immobilization Status: Terminated Trial end date: 2013-06-01 Target enrollment: Participant gender: Summary This is a safety and tolerability study investigating the effect of HPP593 in healthy volunteers during and after limb immobilization. Phase: Phase 1 Details Lead Sponsor: High Point Pharmaceuticals, LLC.